Hib-MenAC

Haemophilus influenzae type b plus Neisseria meningitidis serogroups A and C vaccine · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hib-MenAC, covering 2006-12-08 to 2006-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants [Phase 2]

See pricing